Skip to content

Study · Case report or series · n = 1 · 2023

2 results

Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea.

Kårhus ML, Knudsen E, Knop FK

JCEM case reports29 Nov 2022Cited by 6 (Europe PMC)

PMID37908253 (opens in a new tab)PMCIDPMC10578406 (opens in a new tab)DOI10.1210/jcemcr/luac004 (opens in a new tab)PepBankPUB-37908253
Read at sourcePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a patient with severe bile acid diarrhea, once-weekly semaglutide had minimal effect on symptoms.

    In plain wordsIn one patient with severe bile acid diarrhea, once-weekly semaglutide had little effect on symptoms.

    Peptide
    Semaglutide
    Outcome
    No significant changeBile acid diarrhea symptoms
    Study

    n = 1

    Outcome group
    Gastrointestinal function · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Here, we present a patient with severe BAD who experienced minimal effect of the once-weekly administered GLP-1RA semaglutide
  2. 02HumanCase report or seriesEfficacy outcome

    In a patient with severe bile acid diarrhea, treatment with liraglutide was followed by total remission of symptoms after minimal effect of semaglutide.

    In plain wordsIn one patient with severe bile acid diarrhea, symptoms fully went away during liraglutide treatment after little effect from semaglutide.

    Peptide
    Liraglutide
    Outcome
    DecreaseBile acid diarrhea symptoms
    Study

    n = 1

    Outcome group
    Gastrointestinal function · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Here, we present a patient with severe BAD who experienced minimal effect of the once-weekly administered GLP-1RA semaglutide, but total remission of BAD symptoms during treatment with liraglutide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    12 Oct 2026, 11:11 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:06 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.